Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • cambridgetim
    Junior Member
    • Oct 2011
    • 2

    Chip seq annotation

    Hi All. This is my first post on seq answers.

    I am trying to figure out how to annotate a bed file containing peaks, telling me which peaks are located next to which genes.

    I have figured out three options by Googling:

    1. Cistrome peak2gene option

    2. Bioconductor's ChIPpeakAnno

    3. Also, this is a little more tenuous, but I gather I can UCSC's table browser, make a bed file containing locations of genes and use bedtools to compare this with the bed file containing my peak data.


    Any advice on how these 3 approaches compare?

    Link to table browser here:
  • ETHANol
    Senior Member
    • Feb 2010
    • 308

    #2
    This is a really nice work flow.



    Doesn't exactly annotate your bed files but it does give you a list of genes of which your protein of interest binds to, which I am guessing is what you want.
    --------------
    Ethan

    Comment

    • cambridgetim
      Junior Member
      • Oct 2011
      • 2

      #3
      Thanks ETHANol. I need a little more context. Or more specifically, my boss is going to ask for details like:

      1. how does this method compare to other methods?
      2. how do most people normally do this?

      Thanks for your help.

      Comment

      • ETHANol
        Senior Member
        • Feb 2010
        • 308

        #4
        1. This isn't one of those things like mapping or peak calling where there are qualitative/qualitative differences between methods. This methods simply give you the promoters of genes your txt factor binds to. There may be other methods that save you time.

        2. I have no idea how 'most people' do it. I'm sure a lot of people do it differently. The key is finding a workflow that works for you and your data set. For instance you mention a Bioconductor package. I find everything from Bioconductor to be a real pain to figure out. Other people are really good with R-based workflows so they'll go straight to them.

        Figure out the question you want to answer and devise a work flow that brings you to the answer.
        --------------
        Ethan

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        21 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        19 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        26 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        38 views
        0 reactions
        Last Post SEQadmin2  
        Working...